BusinessAI imageTheravance Biopharma Shareholders Approve Merger with Zymeworks
Shareholders of Theravance Biopharma have approved the merger with Zymeworks. This decision marks a significant step in the companies' consolidation, aiming to combine their resources and expertise. The merger is expected to enhance their competitive position in the biopharmaceutical industry and accelerate innovation and development of new therapies.
Investing भारत·




